[Effect of pentagastrin on the survival of allogenic grafts from fetal rat intestine].
Pentagastrin is not known as an immunomodulatoring drug. The aims of the present study were to create an optimal schedule for pentagastrin administration and to evaluate its influence on the allogenic foetal intestinal graft survival and the recipient condition in rats. An allogenic foetal intestinal graft was performed in rats treated by pentagastrin 1 mg/kg/day and in controls. Biomorphometry and histology of the graft was regularly studied and biochemical, hematological, immunological and morphological parameters were determined in a maximal observation time of 19.5 months. Pentagastrin treatment, 1 mg/kg/day, significantly increased the graft survival in rats and. In 50% of the cases, tolerance was reached without any damage for the recipients. This may be due to additional effects of mild immunodepressive and trophic influences of pentagastrin, which have to be confirmed and which could be useful in adult intestine transplantation.